The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

MILBEMAX chewable tablets for dogs

12.5, 125.0 mg/tablet Chewable tablet

Elanco GmbHVPA22020/008/004

Main Information

Trade NameMILBEMAX chewable tablets for dogs
Active SubstancesMilbemycin oxime
Strength12.5, 125.0 mg/tablet
Dosage FormChewable tablet
Licence HolderElanco GmbH
Licence NumberVPA22020/008/004

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndoparasiticide


Licence Issued22/04/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back